DFG approves extension for TU Dresdens 2 Collaborative Research Centresin the fields of

May 27, 2016

SFB 940 "Volition and Cognitive Control: Mechanisms, Modulators and Dysfunctions"

Elucidating the cognitive and neural mechanisms underlying self-control and volitional action


Which cognitive mechanisms and neural systems underlie the ability to exert volitional control over one's actions and emotions? Why do people frequently fail to resist short-term temptations or fail to overcome strong competing habits while pursuing important long-term goals? Why does volitional control break down in mental disorders such as addictions or eating disorders? These are some of the core questions that are investigated at TU Dresden's Collaborative Research Centre (CRC 940) "Volition and Cognitive Control: Mechanisms, Modulators and Dysfunctions", which has been funded by the DFG since 2012. The interdisciplinary research team consists of psychologists and cognitive neuroscientists at the TU Dresden and cooperation partners of the Charité Berlin and is led by Prof. Thomas Goschke. Based on the CRC's excellent evaluation by an international review committee, the DFG has now approved a second funding period of four years, with a funding volume of over 10 million Euros.

The CRC's goal is to elucidate the cognitive and neural mechanisms underlying the ability to exert volitional control over one's actions and emotions as well as to investigate impairments of self-control in selected mental disorders. During the first four-year funding period, the CRC has gained numerous novel insights into the mechanisms of volitional action control. With the help of advanced functional neuroimaging methods, they were able to determine in which regions of the prefrontal cortex intentions are maintained prior to their execution and, if necessary, are shielded against disruptive environmental stimuli or unwanted behavioural impulses. Furthermore, major advances were made in elucidating brain systems governing the control of flexible, goal-directed action in contrast to automatic or habitual behaviour.

Building on these insights, in the second funding period the scientists will examine if dysfunctions in brain systems mediating cognitive control constitute a risk factor, which predicts an increased proneness to commit daily self-control failures or to develop addictive behaviours. Further aims are to examine why volitional self-control is impaired under chronic stress, how cognitive control is modulated by specific neurotransmitter systems and how this modulation changes across the life span, and which neurocognitive mechanisms underlie dysfunctions of cognitive control in anxiety and eating disorders.

Media Inquiries
Prof. Thomas Goschke Tel.: +49 351 463 346 95
Email: thomas.goschke@tu-dresden.de

CRC/Transregio 127: "Biology of xenogeneic cell, tissue and organ transplantation -from bench to bedside"

The DFG will fund a research programme on xenotransplantation for a further four years, which is unparalleled widewide with a total funding volume of over 15 million Euros. It is a collaboration project between TU Dresden, the Ludwig-Maximilian University Munich, the TU Munich and the Medical University Hanover as well as four other research institutions. The prestigious King's College London that is closes connected to TU Dresden, through the "TransCampus" initiated by the Faculty of Medicine Carl Gustav Carus. The goal is to find a solution to the significant shortage of donor organs for patients with heart diseases and diabetes by using genetically modified pig organs and pig cells.

Through this funding Prof. Stefan Bornstein, the speaker for Dresden, and his diabetes team are provided with an opportunity which is unique in the world: to offer new therapies for patients with diabetes and severe fluctuations in the blood sugar levels, using a bio-chamber with insulin-producing pig cells.

Through this funding the Dresden-base university medicine with the Faculty of Medicine and the University hospital Carl Gustav Carus Dresden with be strengthened as a leading diabetes centre.

Web: http://www.klinikum.uni-muenchen.de/SFB-TRR-127/de/index.html

Media Inquiries
Prof. Dr. med. Stefan R. Bornstein, Tel.:+49 351 458 5955
Email: stefan.bornstein@uniklinikum.de
Web: http://mk3.uniklinikum-dresden.de
-end-


Technische Universität Dresden

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.